Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlanbia Regulatory News (GLB)

Share Price Information for Glanbia (GLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.20
Bid: 17.30
Ask: 19.10
Change: -0.23 (-1.25%)
Spread: 1.80 (10.405%)
Open: 18.43
High: 0.00
Low: 0.00
Prev. Close: 18.43
GLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Glanbia increases and extends EUR50m share buyback

4 May 2023 07:05

RNS Number : 3487Y
Glanbia PLC
04 May 2023
 

Glanbia increases and extends existing €50m share buy-back of up to €50m to €100m

4 May 2023, Glanbia plc, the better nutrition company, (the "Company" or the "Group") announces that it has increased and extended its existing share buy-back programme of up to €50 million to up to €100m in total value in Glanbia plc ordinary shares ("Shares"). The purpose of the increased and extended buy-back programme is to further reduce the share capital of the Company (any Shares repurchased for this purpose will be cancelled).

Details of the programme 

The Company has entered into an agreement with J&E Davy ("Davy") to act as principal in relation to the purchase of the Company's Shares, within certain pre-set parameters.

The increased and extended programme will run from 4 May 2023, through to 30 September 2023, unless otherwise terminated in accordance with the Company's agreement with Davy and prevailing authority.

Under the terms of the agreement, Davy will make purchases of the Shares under the buy-back programme independently of, and uninfluenced by, the Company. Purchases may continue during any closed period to which the Company is subject. The Company confirms that it currently has no unpublished inside information.

The increased and extended share buy-back programme will be conducted within the limitations of the Company's general authority to repurchase Shares, and conditional upon the passing of Resolution 10 proposed to be approved by the Company's shareholders at the 2023 Annual General Meeting to be held today, 4 May 2023, up to a maximum of 10% of the issued share capital of the Company as at 3 March 2023, being 27,228,736 Shares.

The programme will be conducted in accordance with Chapter 9 of the Euronext Dublin Listing Rules and the relevant provisions of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation (EU) 2016/1052 (also as in force in the United Kingdom ("UK"), from time to time, including, where relevant, pursuant to the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as the rules of the Central Bank of Ireland.

ENDS

For further information contact:

Glanbia plc +353 56 777 2200 

Mark Garvey, Group Finance Director

Liam Hennigan, Group Secretary & Head of Investor Relations: +353 86 046 8375

Martha Kavanagh, Head of Corporate Communications: +353 87 646 2006 

Davy

Ivan Murphy/Ronan Veale +353 1 679 7788

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUOUAROWUVRUR
Date   Source Headline
13th Nov 201410:25 amRNSDirector/PDMR Shareholding
29th Oct 20147:00 amRNSInterim Management Statement
28th Oct 20143:32 pmRNSDirectorate Change
15th Oct 20147:00 amRNSCompletion of acquisition of Isopure Company, LLC
10th Oct 201412:06 pmRNSDirector/PDMR Shareholding
30th Sep 20146:09 pmRNSDirectorate Change
30th Sep 20143:53 pmRNSTotal Voting Rights
22nd Sep 20146:23 pmRNSDirector/PDMR Shareholding
22nd Sep 201411:02 amRNSBlocklisting Interim Review
12th Sep 20147:00 amRNSAcquisition
20th Aug 20147:00 amRNSHalf Yearly Report
31st Jul 20145:19 pmRNSTotal Voting Rights
7th Jul 20144:47 pmRNSDirector/PDMR Shareholding
30th Jun 20145:23 pmRNSDirector/PDMR Shareholding
30th Jun 20145:09 pmRNSTotal Voting Rights
30th May 201410:13 amRNSDirectorate Change
13th May 20143:25 pmRNSResult of AGM
13th May 20147:00 amRNSInterim Management Statement
12th May 201411:51 amRNSHolding(s) in Company
30th Apr 20149:49 amRNSAppointment of Non-Executive Director
11th Apr 201410:01 amRNSHolding(s) in Company
7th Apr 20145:10 pmRNSNotice of AGM and 2013 Annual Report
31st Mar 201412:21 pmRNSBlocklisting Interim Review
12th Mar 20147:00 amRNSFinal Results
24th Feb 20145:18 pmRNSDirectorate Change
24th Jan 201412:25 pmRNSHolding(s) in Company
23rd Dec 20131:04 pmRNSStatement re 2014 AGM Date
29th Nov 20132:43 pmRNSTotal Voting Rights
14th Nov 20135:56 pmRNSDirector/PDMR Shareholding
12th Nov 201312:30 pmRNSBoard and Management Changes
4th Nov 20134:47 pmRNSDirector/PDMR Shareholding
29th Oct 20137:00 amRNSInterim Management Statement
17th Oct 20134:35 pmRNSPrice Monitoring Extension
23rd Sep 20134:39 pmRNSBlocklisting Interim Review
30th Aug 20134:11 pmRNSTotal Voting Rights
27th Aug 201311:18 amRNSDirector/PDMR Shareholding
21st Aug 20137:00 amRNS2013 Half Year Results
27th Jun 20139:45 amRNSDirectorate Change
14th Jun 20134:44 pmRNSChange of Director
10th Jun 20132:15 pmRNSHolding(s) in Company
6th Jun 20135:27 pmRNSStatement re appointment of Executive Director
31st May 20132:16 pmRNSTotal Voting Rights
31st May 20132:13 pmRNSDirector/PDMR Shareholding
23rd May 20132:00 pmRNSCapital Markets Day Comments
23rd May 201312:02 pmRNSDirector/PDMR Shareholding
22nd May 201311:38 amRNSResult of AGM
21st May 201311:00 amRNSAGM Statement
21st May 20137:00 amRNSBoard & Management Changes
16th May 20137:00 amRNSInterim Management Statement
14th May 20134:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.